(194 days)
The Spiros is a single use, sterile, non-pyrogenic, swab-able, bidirectional valve device intended for use as an accessory to an Intravascular Administration Set. The Spiros provides access for the administration of fluids from a container to a patient's vascular system through the administration needle or catheter (which is inserted into the vein or artery).
The Spinning Spiros is a closed connector which is compatible with and used to access, standard female luers and known needle-free connectors. The Spinning Spiros is a passively closed design which will prevent the leakage of fluid or ingress of air when in the inactivated (resting) state. When activated the luer is an open twoway conduit for fluid flow. The Spinning Spiros is an accessory to an IV administration device including tubing sets and syringes, such that an integral female luer is used to connect to such devices.
The provided text describes a 510(k) summary for the "Spinning Spiros" device. This is a regulatory submission for a medical device seeking clearance based on substantial equivalence to a predicate device, not typically a study reporting detailed performance metrics and acceptance criteria in the way a clinical trial or a formal performance study would.
Therefore, the information requested in your prompt (especially regarding sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, and training set details) is not present in the provided document. This type of regulatory document focuses on demonstrating equivalence to an already marketed device rather than presenting novel performance study data in detail.
However, based on the snippet: "ICU Medical Spinning Spiros closed male luer device has been tested post sterilization and passed all acceptance criteria. The Spinning Spiros closed mate luer meets the functional claims and intended use as described in the product labeling and is safe and effective in terms of substantial equivalence as the predicate device described in this document," we can infer the general nature of the acceptance criteria and the study's conclusion, even if the specifics are not given.
Here's a breakdown of what can be extracted and what is missing based on your prompt:
1. Table of acceptance criteria and the reported device performance:
| Acceptance Criteria (Inferred) | Reported Device Performance (Inferred) |
|---|---|
| Functional equivalence to predicate device (K070532 - Spiros) | "The Spinning Spiros... is equivalent to the predicate device because it does not modify the claim." |
| Prevention of fluid leakage in inactivated state | "The Spinning Spiros is a passively closed design which will prevent the leakage of fluid..." |
| Prevention of air ingress in inactivated state | "The Spinning Spiros is a passively closed design which will prevent... ingress of air when in the inactivated (resting) state." |
| Open two-way conduit for fluid flow when activated | "When activated the luer is an open two-way conduit for fluid flow." |
| Compatibility with standard female luers and needle-free connectors | "The Spinning Spiros is a closed connector which is compatible with and used to access, standard female luers and known needle-free connectors." |
| Single use | "The Spiros is a single use..." |
| Sterile | "The Spiros is a... sterile..." |
| Non-pyrogenic | "The Spiros is a... non-pyrogenic..." |
| Swab-able | "The Spiros is a... swab-able..." |
| Bi-directional valve function | "The Spiros is a... bidirectional valve device..." |
| Mechanical integrity post-sterilization | "ICU Medical Spinning Spiros closed male luer device has been tested post sterilization and passed all acceptance criteria." |
| Safety and effectiveness | "The Spinning Spiros closed mate luer... is safe and effective in terms of substantial equivalence..." |
| No accidental back-off from syringe | "The spin collar adds the feature that the Spinning Spiros won't accidentally back off of a syringe." |
Missing Information (Not Available in the Provided Text):
- Sample size used for the test set and the data provenance: This information is not provided. The document states "has been tested," but no specifics on sample size or whether it was internal company testing, external, etc., are given.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable or not provided. This device is not one that typically requires expert interpretation for "ground truth" in the way an imaging AI model would. It relates to functional and material testing.
- Adjudication method: Not applicable or not provided.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is not an AI-assisted device.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is a physical medical device, not an algorithm.
- The type of ground truth used: For a physical device like this, "ground truth" would be established by physical measurements, functional tests (e.g., flow rate, leak tests, force to connect/disconnect), material testing, and sterilization validation, all performed against engineering specifications and relevant ISO/ASTM standards. The document only generically states "passed all acceptance criteria" and "meets the functional claims."
- The sample size for the training set: Not applicable. This is not an AI/machine learning device.
- How the ground truth for the training set was established: Not applicable.
Summary of the Study (Inferred from the document):
The "study" referenced is likely a series of internal verification and validation tests (V&V) conducted by ICU Medical, Inc. on the Spinning Spiros device. These tests would have been designed to ensure the device met its design specifications and functional requirements, and to demonstrate substantial equivalence to the predicate device (Spiros, K070532). The tests would have included evaluating the device's mechanical integrity (especially after sterilization), fluidic properties (leakage, flow), compatibility with standard luers, and the specific feature of the spinning collar preventing accidental disconnection. The conclusion of these internal studies was that the device met all acceptance criteria, functional claims, and intended uses, deeming it safe and effective and substantially equivalent to its predicate. The specifics of these tests (e.g., protocols, sample sizes, detailed results) are typically found in the full 510(k) submission, not in the publicly available summary.
{0}------------------------------------------------
ICU MEDICAL INC.
R - 3 2009
4455 Atherton Drive Salt Lake City, Utah (801) 264 - 1332, Phone (801) 264 - 1755, Fax Tracy S. Best, Sr. Regulatory Affairs Specialist Preparation Date: April 06, 2009
APR - 6 2009
edical. Inc.
SPECIAL 510(K) Summary of Safety and Effectiveness for the:
Trade Name: Spinning Spiros
Common Name: Accessory to Piston Syringe, Needleless
Classification Name: I.V. Administration Set, Accessory 21 CFR 880.5440, Class II Device
Product Code: FPA
Legally Marketed Predicate Devices for Substantial Equivalence:
*K070532 - Spiros - ICU Medical, Inc.
Rationale for SE:
The Spinning Spiros device is a passively closed - closed male luer or CML. This device is equivalent to the predicate device because it does not modify the claim. The few dimensional changes are necessary for larger cavity molds and for eventual automated assembly. The spin collar adds the feature that the Spinning Spiros won't accidentally back off of a syringe.
Description of Submitted Device:
The Spinning Spiros is a closed connector which is compatible with and used to access, standard female luers and known needle-free connectors. The Spinning Spiros is a passively closed design which will prevent the leakage of fluid or ingress of air when in the inactivated (resting) state. When activated the luer is an open twoway conduit for fluid flow. The Spinning Spiros is an accessory to an IV administration device including tubing sets and syringes, such that an integral female luer is used to connect to such devices.
Intended Use:
The Spiros is a single use, sterile, non-pyrogenic, swab-able, bidirectional valve device intended for use as an accessory to an Intravascular Administration Set. The Spiros provides access for the administration of fluids from a container to a patient's vascular system through the administration needle or catheter (which is inserted into the vein or artery).
Safety and Performance:
ICU Medical Spinning Spiros closed male luer device has been tested post sterilization and passed all acceptance criteria. The Spinning Spiros closed mate luer meets the functional claims and intended use as described in the product labeling and is safe and effective in terms of substantial equivalence as the predicate device described in this document.
Conclusion:
The materials, performance, and operational features of both the submitted device and the predicate devices are substantially equivalent and safe and effective for their intended use.
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three overlapping wing segments, symbolizing service to the nation. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES.USA" is arranged in a circular pattern around the eagle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Tracy Best Senior Regulatory Affairs Specialist ICU Medical, Incorporated 4455 Atherton Drive Salt Lake City, Utah 84123
APR - 6 2009
Re: K082806
Trade/Device Name: Spinning Spiros Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: March 9, 2009 Received: March 10, 2009
Dear Mr. Best:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{2}------------------------------------------------
Page 2 - Mr. Best
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Shula A. Mayberg, MD for S. Rumm, DDS
Susan Runner, D.D.S., MA Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known):
Device Name:
Spinning Spiros
Indications For Use:
The Spiros is a single use, sterile, non-pyrogenic, swab-able, bidirectional valve device intended for use as an accessory to an Intravascular Administration Set. The Spiros provides access for the administration needle or catheter (which is inserted into the vein or artery).
Prescription Use _ XX (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
J.A.Oull.
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: _ Korz 04
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.